東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

A novel concept on incremental cost-...

Jiang, Jing.

Linked to FindBook

Google Book

Amazon

博客來

A novel concept on incremental cost-effectiveness ratio with censored cost data.

Record Type:	Electronic resources : Monograph/item
Title/Author:	A novel concept on incremental cost-effectiveness ratio with censored cost data./
Author:	Jiang, Jing.
Description:	67 p.
Notes:	Source: Dissertation Abstracts International, Volume: 76-02(E), Section: B.
Contained By:	Dissertation Abstracts International76-02B(E).
Subject:	Biostatistics. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3639429
ISBN:	9781321238143

A novel concept on incremental cost-effectiveness ratio with censored cost data.
Jiang, Jing.

A novel concept on incremental cost-effectiveness ratio with censored cost data. - 67 p.

Source: Dissertation Abstracts International, Volume: 76-02(E), Section: B.

Thesis (Ph.D.)--The University of Texas School of Public Health, 2014.

The incremental cost-effectiveness ratio (ICER), defined as the ratio of the difference in cost between two treatments to the difference in effectiveness between those treatments, is the most widely used analytical tool in health economics evaluation research. Although the ICER has gained widespread acceptance, the theoretical foundation of ICER has not been rigorously examined in published studies. ICER estimates calculated by using the means of both cost and effectiveness measures can be highly variable. There is a strong need for a comprehensive statistical framework to ensure consistency in ICER estimations to have a thorough statistical inference on ICER and derive a consistent ICER estimator. We propose a novel method of calculating the ICER for definition of ICER with censored survival data and construct an ICER estimator with the vector of predictive covariates. We extend the methodology using the Cox proportional hazards model to censored cost-effectiveness data analysis, in particular, the estimation of ICER in presence of censoring dataset.

ISBN: 9781321238143Subjects--Topical Terms:

1002712
Biostatistics.

A novel concept on incremental cost-effectiveness ratio with censored cost data.
LDR:02254nmm a2200277 4500 001 2064552
005 20151115152147.5
008 170521s2014 eng d
020 $a 9781321238143
035 $a (MiAaPQ)AAI3639429
035 $a AAI3639429
040 $a MiAaPQ $c MiAaPQ
100 1 $a Jiang, Jing. $3 1267575
245 1 2 $a A novel concept on incremental cost-effectiveness ratio with censored cost data.
300 $a 67 p.
500 $a Source: Dissertation Abstracts International, Volume: 76-02(E), Section: B.
500 $a Adviser: Wenyaw Chan.
502 $a Thesis (Ph.D.)--The University of Texas School of Public Health, 2014.
520 $a The incremental cost-effectiveness ratio (ICER), defined as the ratio of the difference in cost between two treatments to the difference in effectiveness between those treatments, is the most widely used analytical tool in health economics evaluation research. Although the ICER has gained widespread acceptance, the theoretical foundation of ICER has not been rigorously examined in published studies. ICER estimates calculated by using the means of both cost and effectiveness measures can be highly variable. There is a strong need for a comprehensive statistical framework to ensure consistency in ICER estimations to have a thorough statistical inference on ICER and derive a consistent ICER estimator. We propose a novel method of calculating the ICER for definition of ICER with censored survival data and construct an ICER estimator with the vector of predictive covariates. We extend the methodology using the Cox proportional hazards model to censored cost-effectiveness data analysis, in particular, the estimation of ICER in presence of censoring dataset.
520 $a To the best of our knowledge, this is the first attempt to incorporate Cox regression analysis in estimating the ICER. The application of our novel methodology to the analysis of the simulation data and the real Surveillance, Epidemiology and End Results (SEER) Medicare data are also described.
590 $a School code: 0219.
650 4 $a Biostatistics. $3 1002712
690 $a 0308
710 2 0 $a The University of Texas School of Public Health. $b Biostatistics. $3 1018615
773 0 $t Dissertation Abstracts International $g 76-02B(E).
790 $a 0219
791 $a Ph.D.
792 $a 2014
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3639429